The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

The drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer ...

Cancer is a perennial fear for therapies that ... cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD ...

Scientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...

Dosing can start once again in uniQure's phase 3 trial of its haemophilia B gene therapy, after the FDA concluded that a case of liver cancer seen in the study was unlikely to be caused by the ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

The study suggests that doctors may need to rethink current screening ... Inherited Gene Elevates Prostate Cancer Risk in Affected Families Jan. 28, 2025 — The inherited mutated gene WNT9B ...